Anti-Inflammatory Activities of Leaf Oil from<i> Cinnamomum subavenium In Vitro</i> and<i> In Vivo</i>

Hao, Xincai; Sun, Weiguang; Ke, Changbin; Wang, Fuqian; Xue, Yongbo; Luo, Zengwei; Wang, Xuanbin; Zhang, Jinwen; Zhang, Yonghui

doi:https://doi.org/10.1155/2019/1823149

BioMed Research International

On this page

Abstract Introduction Materials and Methods Results Discussion Conclusions Data Availability Conflicts of Interest Authors’ Contributions Acknowledgments References Copyright Related Articles

Research Article | Open Access

Volume 2019 | Article ID 1823149 | https://doi.org/10.1155/2019/1823149

Anti-Inflammatory Activities of Leaf Oil from Cinnamomum subavenium In Vitro and In Vivo

Xincai Hao,¹Weiguang Sun,²Changbin Ke,¹Fuqian Wang,²Yongbo Xue,²Zengwei Luo,²Xuanbin Wang,¹Jinwen Zhang,³and Yonghui Zhang²

Academic Editor: Stefano Curcio

Received17 Oct 2018

Revised02 Jan 2019

Accepted13 Jan 2019

Published20 Feb 2019

Abstract

The study determined the chemical constituents and anti-inflammatory effects of leaf oil from Cinnamomum subavenium (CS-LO) that has been used in folk medicine to treat various symptoms including inflammation. The anti-inflammatory effects of the oil were evaluated by LPS-stimulated RAW264.7 cells and the Carr-induced hind mouse paw edema model, respectively. In vitro, nitric oxide (NO), prostaglandin E2 (PGE₂), TNF-α, IL-6, and IL-1β were significantly decreased by CS-LO, and the expression of nuclear factor-κB (NF-κB) protein was blocked as well. In in vivo, the malondialdehyde (MDA) and paw edema levels were decreased by CS-LO, and the same result came up on the NO and tumor necrosis factor (TNF-a) of serum at the 5th h after Carr injection. In addition, iNOS and COX-2 immunoreactive cells of the paw tissue were decreased significantly by CS-LO (200 mg/kg) in histological examination. The present findings indicated that CS-LO have anti-inflammatory properties, and the effects might be caused through inhibiting iNOS, COX-2, TNF-α, IL-1β, and IL-6 expression via affecting NF-κB pathway, which will provide a power scientific basis for CS-LO to be used as the treatment of inflammatory diseases.

1. Introduction

The inflammation, associated with pain and swelling, is a series of the multiple biological reactions of body tissues to harmful stimulation. It is self-protective function of organisms to harmful stimuli [1]. Inflammation is used to be a hazardous factor for the onset of some chronic diseases, such as neurological disease, cardiovascular disease, and cancer [2]. Therefore, many studies considered anti-inflammation and antioxidant as a practical way to fight these degenerative diseases [3]. Plant extracts and essential oils, which are rich sources of antioxidant and anti-inflammatory agents, can suppress the release of inflammatory mediators and free radicals and increase antioxidant defenses. They are widely used in food, cosmetics, and medicine for their potential biological activities [4, 5]. Therefore, the use of natural additives is a good way to fight abnormal inflammation and oxidation.

The anti-inflammatory effect of some Cinnamomum oil has been confirmed, such as Cinnamomum osmophloeum, Cinnamomum insularimontanum Hayata, and Cinnamomum cassia. Much of the ingredients of the essential oils belong to terpenes, including monoterpene, sesquiterpene, and their oxidative derivatives. These small molecules tend to diffuse through the membranes to induce biological reactions.

Cinnamomum subavenium. Miq. belong to lauraceae family, which are popular in China, Malaysia, Cambodia, Indonesia, and Burma [6]. Its peel, fruit, and leaves have been used in folk medicine for treating stomachache, carcinomatous swelling, abdominal pain, chest pain, hernia, rheumatism, vomiting, nausea, and diarrhea [7]. Recently, researchers have reported that C. subavenium has potent cytotoxic effects in some tumor cell lines, including urothelial carcinoma cells, colorectal cancer cells, skin cancer melanoma cells, human bladder cancer cells, human lung cancer cell, and human prostate cancer cell lines [7–12]. Moreover, the leaf oil of C. subavenium has potent antioxidant and antimicrobial activities [13]. But, the anti-inflammatory activity of C. subavenium has not been report so far. Therefore, the objectives of our study were to investigate the major chemical composition of leaf oil from C. subavenium using gas chromatography-mass spectroscopy (GC-MS) and assess the anti-inflammatory activities of the leaf oil from C. subavenium (CS-LO).

2. Materials and Methods

2.1. Chemicals and Materials

Indo, LPS (Escherichia coli serotype 0111:B4), λ-carrageenan, and MTT (3-[, 5-dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium bromide) were obtained from Sigma-Aldrich Co. (USA). Prostaglandin E₂ Express ELISA was from Cayman Chemical (USA). TNF-α, IL-1β, and IL-6 ELISA were from Boster Biological Engineering Co., Ltd. (China). Anti-iNOS, anti-COX-2 antibody, and anti-NF-κB p65 antibody were from Santa Cruz Biotechnology (USA). BAY 11-7082 (NF-κB inhibitor) was from Beyotime Institute of Biotechnology (China). The 4-amino-5-methylamino-29,79-difluorofluorescein diacetate (DAF-FM diacetate) was from Invitrogen (USA).

2.2. Plant Materials

Leaves of C. subavenium Miq were collected from China and identified by Changgong Zhang (Huazhong University of Science and Technology). The voucher specimen (No. 2012-0610) has been deposited at the Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology.

2.3. Preparation of CS-LO

500 g fresh leaf of C. subavenium was hydrodistilled for 4 h with a Clevenger-type apparatus. The collected oil, dried with anhydrous sodium sulfate, was stored in brown vials at +4°C.

2.4. Gas Chromatography and Mass Spectrometry Analysis

The constituents of essential oil were identified by gas chromatography-mass spectrometry (GC-MS). MS is equipped with Polaris Q quality selective detector in electron collision ionization mode (70 eV). The chromatographic column was an RTx-5 (25 m x 0.25 mm x 0.25μm), kept 1 minute at 80°C to 200°C at 4°C/min, and kept 5 minutes. The temperature of injector was 250°C, the helium gas flow rate was 10 mL/min, and the split ration was 1:10. Manual injection of diluted samples (1.0μl, 1/100, v/v, ethyl acetate) was in nonshunt mode. The major chemicals of CS-LO were identified by comparison with standard products and retention indices based on their mass spectral fragmentation in The Wiley GC-MS library. The amount of compounds was determined by Peak area of integral spectrograms.

2.5. Cell Viability Assay

The RAW 264.7 cells were obtained from Cell Culture Center of Chinese Academy of Medical Sciences (Beijing, China). The cells were cultured in DMEM supplemented with FBS (10%), streptomycin (100 mg/Ml), and penicillin (100 U/mL) at 37°C in a humidified atmosphere with 5% CO₂ and were subcultured every 3 days. The CS-LO was dissolved in DMSO and diluted with culture medium to target concentration. RAW 264.7 cells (1.5×10⁵) in 96-well plates were treated with 0, 2.5, 5, 10, 20, and 40 μg/mL of CS-LO in LPS at 37°C for 24 h. Adding MTT solution to every well, the cells were incubated for another 4 h at 37°C. And then, the medium was discarded; the formazan crystals were dissolved in DMSO. The absorbance was measured at 570 nm.

2.6. Detection of Intracellular NO, PGE2, TNF-α, IL-1β, and IL-6

NO production was measured by the nitrite levels of the cultured media and serum based on the Griess reaction [14]. RAW 264.7 cells were incubated in 0.2 μg/mL LPS with different CS-LO (2.5, 5, and 10 μg/mL) for 18 h. Then, the collected medium was mixed with the same volume of Griess reagent (1% sulfanilamide and 0.1% naphthylethylenediamine dihydrochloride in 2.5% phosphoric acid). 15 min incubation later, the absorbance was detected at 540 nm using Micro-Reader. RAW 264.7 cells treated with LPS and CS-LO were incubated with DAF-FM (10 µM) diacetate at 37°C for 1 h, and the production of NO was assessed by confocal laser scanning microscopy. The production of PGE₂ was quantified with the Prostaglandin E2 Express EIA Monoclonal Kit. IL-1β, IL-6, and TNF-α were quantified with their ELISA kits under the manufacturer’s instructions.

2.7. Western Blot Analysis

After washing with cold PBS, the stimulated RAW 264.7 cells were lysed in a cold lysis buffer [10% glycerol, 1% Triton X-100, 1 mM Na₃VO₄, 1 mM EGTA, 10 mM NaF, 1 mM Na₄P₂O₇, 20 mM Tris buffer (pH 7.9), 100 mM b-glycerophosphate, 137 mM NaCl, 5 mM EDTA, and one protease inhibitor cocktail tablet (Roche, Indianapolis, IN, USA)] and incubated on ice for 0.5h. The collected supernatants were rapidly frozen. The concentration of the proteins was detected using the BCA method. After denaturation, the proteins of the cell extracts were separated by SDS-polyacrylamide gel electrophoresis. After electroblotted onto a PVDF membrane, they were incubated with blocking solution (5% skim milk) for 12 h at 4°C, and then incubated with primary antibody for 4 h. After washed with Tween 20/Tris-buffered saline (TBST), the blots were incubated with a dilution of horseradish peroxidase-conjugated secondary antibody for 1 h at room temperature. The blots were washed again with TBST and then developed using enhanced chemiluminescence. The quantities of western blot were made by measuring the relative intensity contrasted with the control using Kodak Molecular Imaging Software.

2.8. Carr-Induced Paw Edema

Male Wistar rats (180–220 g), two months old, were provided by the Hubei Provincial Center for Disease Control and Prevention. All animals were kept under 23–25°C conditions and 12 hours of light/12 hours dark cycles. The experiments and animal maintenance followed the animal care and use guidelines of the Institute’s Animal Care and Use Committee of Huazhong University of Science and Technology. The Wistar rats, injected with 1% Carr (50 μL) in the plantar side of right hind paws by 30min in advance, were administered with CS-LO (50, 100, and 200 mg/kg, p.o.), Indo (10 mg/kg, p.o.), and the vehicle (pure water + CMC 0.5%). The volume of paw was measured using a plethysmometer (model YLS-7B, Zhong Hao, Peking, China) before Carr injection and every hour after administration of the edematogenic agent for 5 h. The degree of edema (%) was measured by the ratio ((V1−V0)/V0), where V0 is the normal volume before injection, and V1 is the pathological volume after Carr injection. Finally, the rats were sacrificed; the collected blood and Carr-induced edema feet were stored at -80°C until analysis.

After being homogenized in PBS (pH 7.2) and centrifuged at 12000 × g for 5 min, the collected supernatants were stored at -20°C for MDA determination. The collected serum was stored at -20°C for the NO, PEG2, and TNF-α assay.

2.9. MDA Assay

MDA of the paw edema tissue was measured with the thiobarbituric acid reacting substance (TBARS) [15]. In brief, MDA was used to react with thiobarbituric acid to form a red-complex TBARS under high temperature and acidic conditions, and then it was determined at 532 nm.

2.10. Histological Examination

Histological examination was performed based on the methods by Huang et al. [16]. Briefly, after being dehydrated by ethanol, the tissue sections were paraffinized. After deparaffinization, some sections (thickness, 7µm) were stained with hematoxylin and eosin (H&E); the others were processed for iNOS and COX-2 immunohistochemistry staining. BH2 Olympus microscopy was used to observe and photograph the samples. 3-5 tissue slices were randomly chosen from Control, Carr, Indo, and CS-LO-treated groups.

2.11. Statistics: Experimental

Data were presented as the mean ± standard deviation (SD) of three parallel measurements. The statistical significance was evaluated by one-way analysis of variance (ANOVA). Statistical significance is expressed as p < 0.05, p < 0.01, and p < 0.001.

3. Results

3.1. Chemical Composition of CS-LO

The essential oil was obtained from the leaves of C. subavenium by steam distillation and then analyzed by GC-MS. 39 compounds were identified in the CS-LO (Table 1). The main components included β-cadinene (12.45%), α-muurolene (8.79%), chavicol (6.46%), citral (5.33%), cis-β-ocimene (5.17%), γ-muurolene (4.34%), bornyl acetate (4.15%), α-copaene (3.78%), linalool (3.31%), methyl cinnamate (3.28%), geraniol (3.31%), and 3-allyl-6-methoxyphenol (3.17%). Among the constituents, sesquiterpenoids accounted for the highest fraction at 45.52% of the total, monoterpenoids accounted for 36.82%, and the nonterpenoids group accounted for 15.06%.

3.2. Effects of CS-LO on RAW 264.7 Cell Viability

The toxicity of CS-LO was determined in RAW 264.7 cells by MTT assay; the result is shown in Figure 1(a). Cell viability did not change at 0, 2.5, 5, 10, 20, and 40 μg/mL of CS-LO. These results suggest that there were no toxic to RAW 264.7 cells under 40 μg/mL of CS-LO. Therefore, CS-LO (2.5-10 μg/mL) was used in the subsequent experiments.

(a)

(b)

(c)

(d)

(e)

3.3. Effects of CS-LO on LPS-Induced NO Production

NO production may reflect inflammation; the effect of CS-LO on LPS-induced NO in RAW 264.7 cells was assessed. After treatment with CS-LO and L-NAME (NO inhibitor), the level of NO in RAW 264.7 was evaluated. As shown in Figures 2(a) and 2(b), there was a concentration-dependent inhibition in NO production. The group treated with 10 μg/L CS-LO (p < 0.01) was highly decreased compared to the LPS-alone group, and L-NAME (100 µM) also have a significant inhibition on the NO in RAW 264.7 cells (Figure 2(a)). Moreover, the image of confocal laser scanning microscopy indicates that the NO production was also suppressed by CS-LO (Figure 2(b)).

(a)

(b)

3.4. Effects of CS-LO on LPS-Induced PGE₂ Production

PGE₂ is another important mediator in inflammatory responses. Decreasing the PGE₂ production would be an effective strategy for suppressing inflammation. As shown in Figure 1(b), PGE₂ was inhibited by CS-LO. Especially, there was a significant inhibition on the expression of PGE₂ at the 10 µg/mL of CS-LO.

3.5. Effects of CS-LO on LPS-Induced TNF-α, IL-1β, and IL-6

TNF-α, IL-1β, and IL-6 are some important proinflammatory cytokines linked with the immunopathology inflammatory diseases. After stimulation with LPS (0.2 µg/mL) and treatment with CS-LO, TNF-α, IL-1β, and IL-6 were detected by ELISA. As shown in Figures 1(c), 1(d), and 1(e), TNF-α, IL-1β, and IL-6 were upregulated after treated with the LPS. However, the inhibition of CS-LO on TNF-α, IL-1β, and IL-6 was in a dose-dependent manner.

3.6. Effects of CS-LO on NF- κB Activity in RAW 264.7 Cells

The NF-κB transcription factor plays a key role in the expression of some cytokines and inflammatory enzymes, such as iNOS, COX-2, TNF-α, IL-1β, and IL-6. To determine whether CS-LO affects NF-кB pathway, NF-кB p65, a major subunit of NF-кB, was assessed in the presence or absence of CS-LO using western blot. As shown in Figures 3(a) and 3(b), the expression of NF-кB p65 was increased significantly with absence of CS-LO in RAW 264.7 cells. However, the p65 (Figure 3(a)) was inhibited in concentration-dependent manner in cells with CS-LO.

(a)

(b)

3.7. Effects of CS-LO on Carr-Induced Rats Paw Edema

The effects of CS-LO on acute inflammation were tested with the Carr-induced paw edema model. As shown in Figure 4(a), there was a dose-related inhibition of CS-LO to hind paw edema. Especially at 200 mg/kg, CS-LO significantly inhibited (p < 0.01) the development of Carr-induced paw edema. Indo (10 mg/kg) significantly decreased the Carr-induced paw edema as well.

(a)

(b)

(c)

(d)

(e)

3.8. Effects of CS-LO on the MDA Level

MDA was measured to evaluate the ability of CS-LO to radicals. As shown in Figure 4(b), there was a higher level of MDA in paw tissue at 5 h after Carr injection (p < 0.01). However, dose-related inhibition of the MDA level was observed in paw tissue at 5 h after treatment with CS-LO (50, 100, and 200 mg/kg); CS-LO at 100 and 200 mg/kg significantly decreased the MDA level in the paw tissue (p < 0.01), the same with Indo (10 mg/kg) (Figure 4(b)).

3.9. Effects of CS-LO on the NO Level

As shown in Figure 4(c), at 5 h after treatment with Carr (p < 0.01), the NO level increased significantly in the serum of rats. However, the inhibition of CS-LO to NO in the serum of rats was found with a dose-dependent manner, and 200 mg/kg of CS-LO significantly reduced the NO level in the serum (p < 0.01).

3.10. Effects of CS-LO on TNF-α Level

As shown in Figure 4(d), the TNF-α level in the serum increased significantly at 5 h after treatment with Carr (p < 0.01). However, CS-LO highly reduced the TNF-α in the serum, and 200 mg/kg of CS-LO significantly reduced TNF-α level in the serum (p < 0.01).

3.11. Effect of CS-LO on PGE₂ Level

As shown in Figure 4(e), the PGE₂ level in the serum increased significantly at 5 h after treatment with Carr (p < 0.01). However, CS-LO decreased PGE₂ in the serum with a dose-dependent manner, and CS-LO (100 and 200 mg/kg) highly inhibited the level of PGE₂ (p < 0.01).

3.12. Histological Examination

The histological appearance showed a normal appearance of tissue without any significant lesions in the control group (Figure 5(a)). Haemorrhage and a large number of neutrophils infiltrated the interstitial tissue in Carr-treated group (Figure 5(b)). CS-LO (200 mg/kg) and Indo reduced the number of neutrophils compared with the Carr-treated group (Figures 5(c) and 5(d)). There were no inflammation, iNOS, and COX-2 immunoreactive cells (Figures 5(e) and 5(i)); however, a large number of iNOS and COX-2 immunoreactive cells were found in brown parts of the plantar biopsy tissue at 5 h after injection of Carr (Figures 5(f) and 5(j)). Indo and CS-LO (200 mg/kg) significantly inhibited the iNOS and COX-2 immunoreactive cells in the paw tissue (Figures 5(g), 5(h), 5(k), and 5(l)).

(a) Control

(b) Carr

(c) Carr+Indo

(d) Carr+CS-LO

(e) Control

(f) Carr

(g) Carr+Indo

(h) Carr+CS-LO

(i) Control

(j) Carr

(k) Carr+Indo

(l) Carr+CS-LO

Figure 5

Histological observation of rat hind footpads after injecting Carr 0.9% saline (control group) or Carr. (a-d) H&E staining of footpad tissue sections from rat in each group. (e-h) iNOS immunohistochemical staining of footpad tissue sections from rat in each group. (i-l) COX-2 immunohistochemical staining of footpad tissue sections from rat in each group. Scale bar = 50 µm. The infiltrating cells were predominantly neutrophils (N; arrows). The brown staining indicates the interaction of primary and secondary antibodies and the presence of iNOS and COX-2.

4. Discussion

Inflammation is mediated by a series of free radicals and inflammatory cytokines. Excessive or persistent generation of these inflammatory mediators may cause diseases, such as arthritis, diabetes, atherosclerosis, and some types of cancer [17]. During inflammation, the activated macrophages are the source of inflammatory cytokines, which were important cells for phagocytosis and molecular immunology [18]. Moreover, many researches showed that the inflammatory free radicals could be induced by l-carrageenan (Carr), which was the suitable way to study the inflammatory effect.

Previous studies had demonstrated the bioactivity of the C. subavenium. For example, Wang et al. demonstrated the stems of C. subavenium had good pigmentation inhibitory abilities [12]. Cheng et al. found that the leaves and stems of C. subavenium had antioxidative activities [19]. Ho et al. reported that the leaf oils of C. subavenium had good antimicrobial activities [13]. Chen et al. reported the extraction of C. subavenium leaves had inhibition to various cancer cell lines [20]. So in this study, we analyzed the leaf oil of C. subavenium by GC-MS, and anti-inflammatory effects with LPS-induced RAW264.7 cells and Carr-induced paw edema in mice.

Chemical analysis revealed that there are 39 compounds in CS-LO, sesquiterpenoids account for the highest fraction of 45.52%, monoterpenoids account for 36.82%, and the nonterpenoids group account for 15.06%. Moreover, there was no dominant compound in CS-LO. Therefore, the biological activity may be due to the effects of minor ingredients or synergetic effects among the ingredients.

The proinflammatory cytokines NO and PGE₂ plays important roles in inflammatory diseases. NO is an endogenous free radical substance synthesized from -arginine by nitric oxide synthase (NOS) in various animal cells and tissues [21]. PGE₂ is mediated by cyclooxygenase (COX), which has COX-1 and COX-2 isoforms. Therefore, the inhibition of NO and PGE₂ is an effective strategy for inhibiting inflammation [22]. Our result showed that the production of NO and PGE₂ was significantly inhibited by CS-LO (Figures 2 and 1(b)); we also found that CS-LO downregulated iNOS and COX-2 with immunohistochemical staining (Figures 5(h) and 5(l)). Thus, the anti-inflammatory effect of CS-LO may due to its inhibition of NO and PGE₂ via blocking the expression of iNOS and COX-2.

TNF-α, IL-6, and L-1β, a few of important proinflammatory mediators, play important roles in mediating and regulating inflammation in vitro and in vivo. TNF-α, one of the cytokines produced mainly by activated macrophages, can promote inflammatory activity by regulating some adhesion molecules [23]. IL-6 can promote the differentiation of T and B lymphocytes and the release of some inflammatory cytokines [24]. IL-1β was one of the earliest expressed proinflammatory cytokines [25]. Overexpression of both IL-6 and IL-1β is considered to be an important role in the pathophysiology of rheumatoid arthritis [26]. In this study, TNF-α, IL-1β, and IL-6 level, which were highly increased by LPS, were inhibited by CS-LO (Figures 1(c), 1(d), and 1(e)).

NF-κB plays an important role in regulating immune system and inflammatory processes. Activated NF-κB regulates the transcription of inflammatory cytokines and enzymes, such as iNOS, COX-2, TNF-α, IL-1β, and IL-6 [27]. NF-κBp65, a signal for NF-κB activation, played an important role in the regulation of its transcriptional capacity. Once the NF-κBp65 is activated and phosphorylated, it could promote proinflammatory cytokines [28]. Therefore, NF-κB signaling pathway is considered to be a therapeutic route against inflammatory diseases. Our findings suggest that CS-LO suppressed the nuclear translocation of p65 in a concentration-dependent manner (Figure 3). Therefore, CS-LO might regulate the transcription of COX-2, iNOS, and other inflammatory cytokines by antagonizing the transcriptional activity of NF-κB.

Carr-induced paw edema could cause the peripheral release of inflammatory cytokines and mediators in tissue [29]; it is a common model to study inflammation. After administrating with Carr, the edema will rise to the high level, PGE2, TNF-α, and NO will be released during 1–5 h, and the malondialdehyde (MDA) will be produced by free radical attack on the membrane [30]. Edema and MAD are important criteria to evaluate anti-inflammatory activity of natural products [31]. Our results showed that CS-LO significantly decreased the paw edema at 5 h after treatment with Carr (Figure 4(a)), the MDA level was also significantly decreased (Figure 4(b)). These findings indicate that CS-LO has a potent anti-inflammatory activity in vivo. NO, PGE₂, and TNF-α play an important role in inflammatory response [32]. Our results revealed that CS-LO decreased the NO, PGE₂ and TNF-α level after treatment with Carr (Figures 4(c), 4(d), and 4(e)). We also found that CS-LO downregulated neutrophils with H＆E staining (Figure 5(d)). These results, along with the significant suppression of LPS-induced NO, PGE₂ and TNF-a by CS-LO in macrophages, suggest that the anti-inflammatory effects of CS-LO might due to its suppression of NO, PGE₂, and TNF-α synthesis in the peripheral tissues.

5. Conclusions

In summary, CS-LO showed potent anti-inflammatory properties. These activities may be due to the effects of minor components or synergetic effects of the components. The current study also demonstrated that CS-LO not only inhibited iNOS and COX-2 expression and the subsequent production of NO and PGE₂ but also reduced the expression of IL-1β, IL-6, and TNF-α in vitro and in vivo. Moreover, the inhibition of CS-LO was related to inactivation of NF-κB. The results of this study indicate that the leaf essential oil of C. subavenium is a potential anti-inflammatory agent. The Conclusions section should clearly explain the main findings and implications of the work, highlighting its importance and relevance.

Data Availability

All the data used to support the finding of this study are included within the article.

Conflicts of Interest

The authors have no conflicts of interest.

Authors’ Contributions

Xincai Hao and Weiguang Sun contributed equally to this work.

Acknowledgments

This project was financially supported by Hubei Provincial Outstanding Young and Middle-Aged Science and Technology Innovation Team Project (Grant no. T201813), the Young Scientist Innovation Team Project of Hubei Colleges (no. T201510), and the Hubei Province Health and Family Planning Scientific Research Project (no. WJ2017Z023).

References

N. Liang, Y. Sang, W. Liu, W. Yu, and X. Wang, “Anti-Inflammatory Effects of Gingerol on Lipopolysaccharide-Stimulated RAW 264.7 Cells by Inhibiting NF-κB Signaling Pathway,” Inflammation, vol. 41, no. 3, pp. 835–845, 2018.
View at: Publisher Site | Google Scholar
P. C. Calder, R. Albers, J. Antoine et al., “Inflammatory Disease Processes and Interactions with Nutrition,” British Journal of Nutrition, vol. 101, no. S1, pp. 1–45, 2009.
View at: Publisher Site | Google Scholar
M. Zhang, N. S. Hettiarachchy, R. Horax et al., “Phytochemicals, antioxidant and antimicrobial activity of Hibiscus sabdariffa, Centella asiatica, Moringa oleifera and Murraya koenigii leaves,” Journal of Medicinal Plants Research, vol. 5, no. 30, pp. 6672–6680, 2011.
View at: Publisher Site | Google Scholar
G. Oboh, “Effect of blanching on the antioxidant properties of some tropical green leafy vegetables,” LWT - Food Science and Technology, vol. 38, no. 5, pp. 513–517, 2005.
View at: Publisher Site | Google Scholar
M. Tiwari, U. N. Dwivedi, and P. Kakkar, “Suppression of oxidative stress and pro-inflammatory mediators by Cymbopogon citratus D. Stapf extract in lipopolysaccharide stimulated murine alveolar macrophages,” Food and Chemical Toxicology, vol. 48, no. 10, pp. 2913–2919, 2010.
View at: Publisher Site | Google Scholar
C. Lin, C. Chen, T. Lin, J. C. Tung, and S. Wang, “Anti-inflammation activity of fruit essential oil from Cinnamomum insularimontanum Hayata,” Bioresource Technology, vol. 99, no. 18, pp. 8783–8787, 2008.
View at: Publisher Site | Google Scholar
C.-H. Liu, C.-Y. Chen, A.-M. Huang, and J.-H. Li, “Subamolide A, a component isolated from Cinnamomum subavenium, induces apoptosis mediated by mitochondria-dependent, p53 and ERK1/2 pathways in human urothelial carcinoma cell line NTUB1,” Journal of Ethnopharmacology, vol. 137, no. 1, pp. 503–511, 2011.
View at: Publisher Site | Google Scholar
C.-Y. Chen, C.-H. Chen, C.-H. Wong et al., “Cytotoxic constituents of the stems of Cinnamomum subavenium,” Journal of Natural Products, vol. 70, no. 1, pp. 103–106, 2007.
View at: Publisher Site | Google Scholar
S.-Y. Kuo, T.-J. Hsieh, Y.-D. Wang, W.-L. Lo, Y.-R. Hsui, and C.-Y. Chen, “Cytotoxic constituents from the leaves of Cinnamomum subavenium,” Chemical & Pharmaceutical Bulletin, vol. 56, no. 1, pp. 97–101, 2008.
View at: Publisher Site | Google Scholar
R.-J. Lin, W.-L. Lo, Y.-D. Wang, and C.-Y. Chen, “A novel cytotoxic monoterpenoid from the leaves of Cinnamomum subavenium,” Natural Product Research (Formerly Natural Product Letters), vol. 22, no. 12, pp. 1055–1059, 2008.
View at: Publisher Site | Google Scholar
K.-H. Shen, E.-S. Lin, P.-L. Kuo, C.-Y. Chen, and Y.-L. Hsu, “Isolinderanolide B, a butanolide extracted from the stems of Cinnamomum subavenium, inhibits proliferation of T24 human bladder cancer cells by blocking cell cycle progression and inducing apoptosis,” Integrative Cancer Therapies, vol. 10, no. 4, pp. 350–358, 2011.
View at: Publisher Site | Google Scholar
H.-M. Wang, C.-C. Chiu, P.-F. Wu, and C.-Y. Chen, “Subamolide E from Cinnamomum subavenium induces sub-G1 cell-cycle arrest and caspase-dependent apoptosis and reduces the migration ability of human melanoma cells,” Journal of Agricultural and Food Chemistry, vol. 59, no. 15, pp. 8187–8192, 2011.
View at: Publisher Site | Google Scholar
C.-L. Ho, E. I.-C. Wang, X.-T. Wei, S.-Y. Lu, and Y.-C. Su, “Composition and bioactivities of the leaf essential oils of cinnamomum subavenium Miq. From Taiwan,” Journal of Essential Oil Research, vol. 20, no. 4, pp. 328–334, 2008.
View at: Publisher Site | Google Scholar
G. J. Huang, S. S. Huang, S. S. Lin et al., “Analgesic effects and the mechanisms of anti-inflammation of ergostatrien-3β-ol from Antrodia camphorata submerged whole broth in mice,” Journal of Agricultural and Food Chemistry, vol. 58, no. 12, pp. 7445–7452, 2010.
View at: Publisher Site | Google Scholar
S. S. Huang, C. S. Chiu, H. J. Chen et al., “Antinociceptive activities and the mechanisms of anti-inflammation of asiatic acid in mice,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 895857, 10 pages, 2011.
View at: Google Scholar
G.-J. Huang, S. S. Huang, and J.-S. Deng, “Anti-inflammatory activities of inotilone from Phellinus linteus through the inhibition of MMP-9, NF-κB, and MAPK activation in vitro and in vivo,” PLoS ONE, vol. 7, no. 5, Article ID e35922, 2012.
View at: Publisher Site | Google Scholar
M. Martínez-Cayuela, “Oxygen free radicals and human disease,” Biochimie, vol. 77, no. 3, pp. 147–161, 1995.
View at: Publisher Site | Google Scholar
L. Dong, L. Yin, Y. Zhang, X. Fu, and J. Lu, “Anti-inflammatory effects of ononin on lipopolysaccharide-stimulated RAW 264.7 cells,” Molecular Immunology, vol. 83, pp. 46–51, 2017.
View at: Publisher Site | Google Scholar
K. C. Cheng, H. A. Chen, P. F. Wu, W. L. Yang, H. M. Wang, and C. Y. Chen, “Three novel antioxidants from Cinnamomum plants,” African Journal of Biotechnology, vol. 11, pp. 4463–4466, 2012.
View at: Google Scholar
C.-Y. Chen, W.-L. Yang, and Y.-R. Hsui, “A novel sesquiterpenoid from the roots of Cinnamomum subavenium,” Natural Product Research (Formerly Natural Product Letters), vol. 24, no. 5, pp. 423–427, 2010.
View at: Publisher Site | Google Scholar
Y.-T. Tung, M.-T. Chua, S.-Y. Wang, and S.-T. Chang, “Anti-inflammation activities of essential oil and its constituents from indigenous cinnamon (Cinnamomum osmophloeum) twigs,” Bioresource Technology, vol. 99, no. 9, pp. 3908–3913, 2008.
View at: Publisher Site | Google Scholar
S.-J. Heo, W.-J. Yoon, K.-N. Kim et al., “Anti-inflammatory effect of fucoxanthin derivatives isolated from Sargassum siliquastrum in lipopolysaccharide-stimulated RAW 264.7 macrophage,” Food and Chemical Toxicology, vol. 50, no. 9, pp. 3336–3342, 2012.
View at: Publisher Site | Google Scholar
K.-N. Kim, Y.-J. Ko, H.-M. Yang et al., “Anti-inflammatory effect of essential oil and its constituents from fingered citron (Citrus medica L. var. sarcodactylis) through blocking JNK, ERK and NF-kappaB signaling pathways in LPS-activated RAW 264.7 cells,” Food and Chemical Toxicology, vol. 57, pp. 126–131, 2013.
View at: Publisher Site | Google Scholar
B. Aggarwal, “Tumor necrosis factors: developments during the last decade,” European Cytokine Network, vol. 7, pp. 93–124, 1996.
View at: Google Scholar
M. Seppola, A. N. Larsen, K. Steiro, B. Robertsen, and I. Jensen, “Characterisation and expression analysis of the interleukin genes, IL-1β, IL-8 and IL-10, in Atlantic cod (Gadus morhua L.),” Molecular Immunology, vol. 45, no. 4, pp. 887–897, 2008.
View at: Publisher Site | Google Scholar
W. K. Jung, I. Choi, D. Y. Lee et al., “Caffeic acid phenethyl ester protects mice from lethal endotoxin shock and inhibits lipopolysaccharide-induced cyclooxygenase-2 and inducible nitric oxide synthase expression in raw 264.7 macrophages via the P38/ERK and NF-KB pathways,” The International Journal of Biochemistry & Cell Biology, vol. 40, no. 11, pp. 2572–2582, 2008.
View at: Publisher Site | Google Scholar
H. Liou, “Regulation of the immune system by NF-kappaB and IkappaB,” Journal of Biochemistry and Molecular Biology, vol. 35, no. 6, pp. 537–546, 2002.
View at: Google Scholar
A. Oeckinghaus and S. Ghosh, “The NF-kappaB family of transcription factors and its regulation,” Cold Spring Harbor Perspectives in Biology, vol. 1, no. 4, Article ID a000034, 2009.
View at: Publisher Site | Google Scholar
M.-H. Huang, S.-S. Huang, B.-S. Wang et al., “Antioxidant and anti-inflammatory properties of Cardiospermum halicacabum and its reference compounds ex vivo and in vivo,” Journal of Ethnopharmacology, vol. 133, no. 2, pp. 743–750, 2011.
View at: Publisher Site | Google Scholar
M.-H. Huang, B.-S. Wang, C.-S. Chiu et al., “Antioxidant, antinociceptive, and anti-inflammatory activities of Xanthii Fructus extract,” Journal of Ethnopharmacology, vol. 135, no. 2, pp. 545–552, 2011.
View at: Publisher Site | Google Scholar
R. L. Handy and P. K. Moore, “A comparison of the effects of L-NAME, 7-NI and L-NIL on carrageenan-induced hindpaw oedema and NOS activity,” British Journal of Pharmacology, vol. 123, no. 6, pp. 1119–1126, 1998.
View at: Publisher Site | Google Scholar
G.-J. Huang, J.-S. Deng, S.-S. Huang et al., “Anti-inflammatory activities of 6β-acetoxy-7α-hydroxyroyleanone from Taiwania cryptomerioides Hayata ex Vivo and in Vivo,” Journal of Agricultural and Food Chemistry, vol. 59, no. 20, pp. 11211–11218, 2011.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2019 Xincai Hao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

1587

Downloads

1424

Citations

BioMed Research International

Anti-Inflammatory Activities of Leaf Oil from Cinnamomum subavenium In Vitro and In Vivo

Abstract

1. Introduction

2. Materials and Methods

2.1. Chemicals and Materials

2.2. Plant Materials

2.3. Preparation of CS-LO

2.4. Gas Chromatography and Mass Spectrometry Analysis

2.5. Cell Viability Assay

2.6. Detection of Intracellular NO, PGE2, TNF-α, IL-1β, and IL-6

2.7. Western Blot Analysis

2.8. Carr-Induced Paw Edema

2.9. MDA Assay

2.10. Histological Examination

2.11. Statistics: Experimental

3. Results

3.1. Chemical Composition of CS-LO

3.2. Effects of CS-LO on RAW 264.7 Cell Viability

3.3. Effects of CS-LO on LPS-Induced NO Production

3.4. Effects of CS-LO on LPS-Induced PGE2 Production

3.5. Effects of CS-LO on LPS-Induced TNF-α, IL-1β, and IL-6

3.6. Effects of CS-LO on NF- κB Activity in RAW 264.7 Cells

3.7. Effects of CS-LO on Carr-Induced Rats Paw Edema

3.8. Effects of CS-LO on the MDA Level

3.9. Effects of CS-LO on the NO Level

3.10. Effects of CS-LO on TNF-α Level

3.11. Effect of CS-LO on PGE2 Level

3.12. Histological Examination

4. Discussion

5. Conclusions

Data Availability

Conflicts of Interest

Authors’ Contributions

Acknowledgments

References

Copyright

3.4. Effects of CS-LO on LPS-Induced PGE₂ Production

3.11. Effect of CS-LO on PGE₂ Level